Noven Pharmaceuticals News and Activities

Noven Pharmaceuticals is owned by Hisamitsu Pharmaceutical.

Hisamitsu Pharmaceutical is one of the...

• TOB Iconic 10,000;
• Topix.

Hisamitsu Pharmaceutical is a company listed under the stock ticker 4530 (JP).

Hisamitsu Pharmaceutical has a direct presence in 2 countries.

View the org chart displaying its 3 main executives

Most searched biographies at Noven Pharmaceuticals

• Naruhito Higo, Chairman of the Board and Chief Executive Officer
• John Choi, Vice President, Chief Financial Officer and Treasurer
• Joel Lippman, Chief Operating Officer and Chief Medical Officer

Create your alert
to follow the executive moves at Noven Pharmaceuticals.

Hisamitsu Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Noven Pharmaceuticals

• Press Releases - Noven
• Press Releases - Noven
• Press Releases - Noven

Social media about Noven Pharmaceuticals

• Noven Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Noven Pharmaceuticals on LinkedIn, X (Twitter) & YouTube